0      0

AONN+ Midyear 2022

FRI07 - ERLEADA: For the Treatment of Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC)| Presentation by Janssen


May 13, 2022 12:00pm ‐ May 13, 2022 1:15pm


Speaker(s):

You must be logged in and own this session in order to post comments.